278 related articles for article (PubMed ID: 15869545)
1. Successful treatment of malignant melanoma in situ with topical 5% imiquimod cream.
Ray CM; Kluk M; Grin CM; Grant-Kels JM
Int J Dermatol; 2005 May; 44(5):428-34. PubMed ID: 15869545
[TBL] [Abstract][Full Text] [Related]
2. Melanoma in situ treated successfully using imiquimod after nonclearance with surgery: review of the literature.
Ellis LZ; Cohen JL; High W; Stewart L
Dermatol Surg; 2012 Jun; 38(6):937-46. PubMed ID: 22338583
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of persistent melanoma in situ with 5% imiquimod cream.
Muñoz CM; Sánchez JL; Martín-García RF
Dermatol Surg; 2004 Dec; 30(12 Pt 2):1543-5. PubMed ID: 15606836
[TBL] [Abstract][Full Text] [Related]
4. Using topical imiquimod for the management of positive in situ margins after melanoma resection.
Pandit AS; Geiger EJ; Ariyan S; Narayan D; Choi JN
Cancer Med; 2015 Apr; 4(4):507-12. PubMed ID: 25620351
[TBL] [Abstract][Full Text] [Related]
5. Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease.
Fisher GH; Lang PG
Arch Dermatol; 2003 Jul; 139(7):945-7. PubMed ID: 12873904
[No Abstract] [Full Text] [Related]
6. Lentigo maligna (melanoma in situ) treated with imiquimod cream 5%: 12 case reports.
Spenny ML; Walford J; Werchniak AE; Beltrani V; Brennick JB; Storm CA; Perry AE; Chapman MS
Cutis; 2007 Feb; 79(2):149-52. PubMed ID: 17388218
[TBL] [Abstract][Full Text] [Related]
7. Topical imiquimod immunotherapy in the management of lentigo maligna.
Powell AM; Russell-Jones R; Barlow RJ
Clin Exp Dermatol; 2004 Jan; 29(1):15-21. PubMed ID: 14723712
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Outcomes of Melanoma In Situ Treated With Topical 5% Imiquimod Cream: A Retrospective Review.
Park AJ; Paul J; Chapman MS; Samie FH
Dermatol Surg; 2017 Aug; 43(8):1017-1022. PubMed ID: 28328708
[TBL] [Abstract][Full Text] [Related]
9. [Lentigo maligna treated with 5% imiquimod cream].
Martín T; Ojeda A; Martínez S; Vera A
Actas Dermosifiliogr; 2005 Dec; 96(10):700-2. PubMed ID: 16476324
[TBL] [Abstract][Full Text] [Related]
10. [In-transit metastasis in melanoma: Efficacy of topical imiquimod combined with carbon dioxide laser or with electrocautery].
Elfatoiki FZ; Longvert C; Clerici T; Bourgault-Villada I; Roudier-Pujol C; Vasseur E; Saiag P
Ann Dermatol Venereol; 2014 Feb; 141(2):106-10. PubMed ID: 24507204
[TBL] [Abstract][Full Text] [Related]
11. Regression of internal melanoma metastases following application of topical imiquimod to overlying skin.
Miller AK; Dusing R; Meggison A; Aires D
J Drugs Dermatol; 2011 Mar; 10(3):302-5. PubMed ID: 21369648
[TBL] [Abstract][Full Text] [Related]
12. Histologic resolution of melanoma in situ (lentigo maligna) with 5% imiquimod cream.
Chapman MS; Spencer SK; Brennick JB
Arch Dermatol; 2003 Jul; 139(7):943-4. PubMed ID: 12873902
[No Abstract] [Full Text] [Related]
13. Characterization of the cellular infiltrate during successful topical treatment of lentigo maligna with imiquimod.
Michalopoulos P; Yawalkar N; Brönnimann M; Kappeler A; Braathen LR
Br J Dermatol; 2004 Oct; 151(4):903-6. PubMed ID: 15491436
[TBL] [Abstract][Full Text] [Related]
14. Treatment of lentigo maligna with imiquimod cream: a long-term follow-up study of 10 patients.
Van Meurs T; Van Doorn R; Kirtschig G
Dermatol Surg; 2010 Jun; 36(6):853-8. PubMed ID: 20618370
[TBL] [Abstract][Full Text] [Related]
15. Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma.
Bong AB; Bonnekoh B; Franke I; Schön M; Ulrich J; Gollnick H
Dermatology; 2002; 205(2):135-8. PubMed ID: 12218228
[TBL] [Abstract][Full Text] [Related]
16. Clearance of invasive melanoma with topical imiquimod.
Moon SD; Spencer JM
J Drugs Dermatol; 2013 Jan; 12(1):107-8. PubMed ID: 23377337
[TBL] [Abstract][Full Text] [Related]
17. Topical imiquimod clears invasive melanoma.
Grady BE; Spencer JM
Cutis; 2016 Nov; 98(5):E28-E30. PubMed ID: 28040822
[TBL] [Abstract][Full Text] [Related]
18. Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head.
Stockfleth E; Sterry W; Carey-Yard M; Bichel J
Br J Dermatol; 2007 Dec; 157 Suppl 2():41-6. PubMed ID: 18067631
[TBL] [Abstract][Full Text] [Related]
19. [Topical treatment of melanoma skin metastases with imiquimod].
Sigüenza M; Pizarro A; Mayor M; Vidaurrázaga C; Miralles L; González-Beato M; Casado M
Actas Dermosifiliogr; 2005 Mar; 96(2):111-5. PubMed ID: 16476347
[TBL] [Abstract][Full Text] [Related]
20. Use of imiquimod for residual acral melanoma.
Sue GR; Hanlon A; Lazova R; Narayan D
BMJ Case Rep; 2014 Aug; 2014():. PubMed ID: 25188932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]